1053 related articles for article (PubMed ID: 19406345)
1. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
Nieuwlaat R; Eurlings LW; Cleland JG; Cobbe SM; Vardas PE; Capucci A; López-Sendòn JL; Meeder JG; Pinto YM; Crijns HJ
J Am Coll Cardiol; 2009 May; 53(18):1690-8. PubMed ID: 19406345
[TBL] [Abstract][Full Text] [Related]
2. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
[TBL] [Abstract][Full Text] [Related]
3. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
4. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
5. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials.
Vermes E; Tardif JC; Bourassa MG; Racine N; Levesque S; White M; Guerra PG; Ducharme A
Circulation; 2003 Jun; 107(23):2926-31. PubMed ID: 12771010
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Capucci A; Camm AJ; Olsson SB; Andresen D; Davies DW; Cobbe S; Breithardt G; Le Heuzey JY; Prins MH; Lévy S; Crijns HJ;
Eur Heart J; 2005 Nov; 26(22):2422-34. PubMed ID: 16204266
[TBL] [Abstract][Full Text] [Related]
7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
8. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Albert NM; Fonarow GC; Yancy CW; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride M; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Am Heart J; 2010 Feb; 159(2):238-44. PubMed ID: 20152222
[TBL] [Abstract][Full Text] [Related]
9. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Yancy CW; Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Am Heart J; 2009 Apr; 157(4):754-62.e2. PubMed ID: 19332206
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
Dagres N; Nieuwlaat R; Vardas PE; Andresen D; Lévy S; Cobbe S; Kremastinos DT; Breithardt G; Cokkinos DV; Crijns HJ
J Am Coll Cardiol; 2007 Feb; 49(5):572-7. PubMed ID: 17276181
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
12. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
[TBL] [Abstract][Full Text] [Related]
13. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
Nieuwlaat R; Prins MH; Le Heuzey JY; Vardas PE; Aliot E; Santini M; Cobbe SM; Widdershoven JW; Baur LH; Lévy S; Crijns HJ
Eur Heart J; 2008 May; 29(9):1181-9. PubMed ID: 18397874
[TBL] [Abstract][Full Text] [Related]
14. Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).
Albert NM; Fonarow GC; Yancy CW; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride M; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Am J Cardiol; 2010 Jun; 105(12):1773-9. PubMed ID: 20538129
[TBL] [Abstract][Full Text] [Related]
15. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
16. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
17. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
18. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
Circulation; 2010 Aug; 122(6):585-96. PubMed ID: 20660805
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
Savelieva I; John Camm A
Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
